Browsing Journal Articles by Author "Xirasagar, S"
Now showing items 1-4 of 4
-
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease.
Bennett, C.L; Qureshi, Z.P; Sartor, A.O; Norris, L.B; Murday, A; Xirasagar, S; Thomsen, H.S (2012)In 2006, nephrologists in Denmark unexpectedly identified chronic kidney disease (CKD) patients with a new syndrome, nephrogenic systemic fibrosis (NSF). Subsequently, 1603 NSF patients were reported to the Food and Drug ... -
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).
Bennett, C.L; Starko, K.M; Thomsen, H.S; Cowper, S; Sartor, O; Macdougall, I.C; Qureshi, Z.P; Bookstaver, P.B; Miller, A.D; Norris, L.B; Xirasagar, S; Trenery, A; Lopez, I; Kahn, A; Murday, A; Luminari, S; Cournoyer, D; Locatelli, F; Ray, P; Mattison, D.R (2012)Identification of serious adverse drug reactions (sADRS) associated with commonly used drugs can elude detection for years. Reye's syndrome (RS), nephrogenic systemic fibrosis (NSF), and pure red cell aplasia (PRCA) among ... -
Pharmaceutical fraud and abuse in the United States, 1996-2010.
Qureshi, ZP; Sartor, O; Xirasagar, S; Liu, Y; Bennett, C.L (2011) -
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.
Chen, B; Restaino, J; Norris, L; Xirasagar, S; Qureshi, Z.P; McKoy, J.M; Lopez, I.S; Trenery, A; Murday, A; Kahn, A; Mattison, D.R; Ray, P; Sartor, O; Bennett, C.L (2012)Pharmaceutical safety is a public health issue. In 2005, the Connecticut Attorney General (AG) raised concerns over adverse drug reactions in off-label settings, noting that thalidomide was approved to treat a rare illness, ...